White House claims drug pricing progress
The administration is set to announce all 50 states will see most-favored-nation pricing for certain drugs in Medicaid programs.
President Donald Trump is concentrating on drug pricing today, with his administration preparing to declare that most states will receive most-favored-nation pricing for specific drugs within Medicaid programs, according to White House plans disclosed to Semafor first. The White House Council of Economic Advisers forecasts the initiative will yield $27.6 billion in net savings for state governments and $36.6 billion in federal savings over a decade.
Trump is set to welcome the governors of South Dakota, Mississippi, and Arkansas at the Oval Office to highlight advances on reduced drug prices, a strategy Republicans aim to leverage in the upcoming midterms. However, experts have raised doubts about whether the price reductions are solely due to Trump's actions and whether the "GENEROUS" Medicaid payment model would indeed generate substantial savings, considering the significant discounts the program already offers for medications.
A White House official, speaking on condition of anonymity to discuss the event, stated, "This is a clear-cut example of how you can save money in the Medicaid program in a way that strengthens the program as a whole. By achieving lower drug prices, more individuals will have access."
Written by urgent.news from Semafor's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
